All patients | 58.7 | 52.8–64.6 | | | |
Sex | | | | | |
Male | 53.7 | 47.6–59.8 | 0.040 | | |
Female | 66.1 | 54.4–77.8 | | | |
Age (y) | | | | | |
y ≤50 | 69.8 | 61.7–77.8 | 0.024 | | |
50< y ≤60 | 61.6 | 51.5–71.7 | | | |
60< y ≤70 | 53.0 | 49.8–56.3 | | | |
70< y ≤80 | 49.0 | 39.6–58.5 | | | |
Grading | | | | | |
Grade 1 | 78.5 | 66.2–90.8 | <0.001 | | 0.012 |
Grade 2 | 55.4 | 46.9–63.9 | | 1.4 (1.0–2.0) | 0.038 |
Grade 3 | 33.2 | 18.8–7.6 | | 2.5 (1.3–4.5) | 0.004 |
Not assessed | 54.1 | 48.3–59.9 | | 1.6 (1.1–2.2) | 0.009 |
18F-FDG PET uptake | | | | | |
Positive | 53.2 | 49.4–57.0 | <0.001 | | 0.002 |
Negative | 83.1 | 57.0–109.2 | | 0.5 (0.3–0.8) | |
Primary tumor site | | | | | |
Cancer of unknown primary | 65.1 | 47.4–82.7 | 0.007 | | 0.004 |
Lung | 46.2 | 34.1–58.3 | | 0.3 (0.1–0.7) | 0.004 |
Midgut | 77.8 | 61.0–94.6 | | 0.7 (0.3–1.6) | 0.344 |
Others | 65.7 | 31.3–100.1 | | 0.3 (0.1–0.7) | 0.008 |
Pancreas | 54.4 | 49.3–59.6 | | 0.4 (0.2–1.0) | 0.041 |
Rectum | 55.4 | 50.3–60.4 | | 0.5 (0.2–1.0) | 0.063 |
Stomach | 46.9 | 33.3–60.5 | | 0.6 (0.2–1.5) | 0.239 |